| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 1.501 | 46.747 | 27.267 | 97.273 | 159.083 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 1.501 | 46.876 | 27.278 | 97.281 | 163.472 |
| Total Expenses - EUR | - | - | 19 | 0 | 0 | 1.264 | 18.684 | 20.909 | 27.639 | 28.182 |
| Gross Profit/Loss - EUR | - | - | -19 | 0 | 0 | 237 | 28.192 | 6.369 | 69.642 | 135.290 |
| Net Profit/Loss - EUR | - | - | -19 | 0 | 0 | 197 | 27.779 | 6.127 | 58.747 | 114.394 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oxybrain Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 1.129 | 0 | 3.553 | 3.772 | 2.332 |
| Current Assets | - | - | 24 | 24 | 23 | 71 | 33.962 | 38.938 | 100.474 | 136.662 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 16.608 | 8.275 | 30.336 | 121.277 |
| Cash | - | - | 24 | 24 | 23 | 71 | 17.354 | 30.663 | 3.424 | 15.385 |
| Shareholders Funds | - | - | 24 | 24 | 23 | 220 | 27.993 | 34.208 | 77.250 | 114.711 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 0 | 0 | 981 | 5.969 | 8.283 | 27.380 | 24.283 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Oxybrain Srl